Patents-Review.com
🔗 Permalink
Inventor profile of:

Catherine CASTAN

City:

Orlienas

Country:

France

Published Applications:

24

Last publication date:

2015-12-31

Top Assignees for applications by Catherine CASTAN

The entities that hold a legal rights for patent applications filed by inventor CASTAN Catherine:

Recent patent applications by CASTAN Catherine

Catherine CASTAN from Orlienas, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-12-31
US20150374636A1
Human necessities

Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)

 #2 | 2015-12-31
US20150374635A1
Human necessities

Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s)

 #3 | 2015-11-19
US20150328168A1
Human necessities

ORAL FORM, COMPRISING IMMEDIATE-RELEASE COATED PARTICLES OF AT LEAST ONE ACTIVE COMPOUND THAT ARE GRINDING-RESISTANT

 #4 | 2012-06-12
US10415850
-

Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same

 #5 | 2012-01-24
US10826690
-

Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles

 #6 | 2011-06-02
US20110129539A1
Human necessities

ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF AN AQUEOUS SUSPENSION OF MICROCAPSULES FOR MODIFIED RELEASE OF AMOXICILLIN

 #7 | 2011-05-19
US20110117205A1
Human necessities

Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)

 #8 | 2011-04-21
US20110091537A1
Human necessities

Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile

 #9 | 2010-12-09
US20100310667A1
Human necessities

Controlled-release floating pharmaceutical compositions

 #10 | 2010-03-18
US20100068291A1
Human necessities

Oral Medicament Based on a Proton Pump Inhibitor

 #11 | 2010-01-21
US20100015220A1
Human necessities

NIACIN AND NSAID COMBINATION THERAPY

 #12 | 2009-12-17
US20090311315A1
Human necessities

Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists

 #13 | 2009-09-03
US20090220611A1
Human necessities

Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same

 #14 | 2009-05-14
US20090123536A1
Human necessities

Oral Pharmaceutical Form of Losartan

 #15 | 2008-12-11
US20080305160A1
Human necessities

Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form

 #16 | 2008-01-31
US20080026056A1
Human necessities

Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form

 #17 | 2007-09-06
US20070207214A1
Human necessities

Oral pharmaceutical compositions with controlled release and prolonged absorption

 #18 | 2007-07-26
US20070173464A1
Human necessities

Oral ribavirin pharmaceutical compositions

 #19 | 2007-07-19
US20070166378A1
Human necessities

Oral ribavirin pharmaceutical compositions

 #20 | 2007-07-12
US20070160678A1
Human necessities

Microcapsules with modified release of active principles with low solubility for oral delivery

 #21 | 2006-12-07
US20060275376A1
Human necessities

Microcapsules with modified release of active principles with low solubility for oral delivery

 #22 | 2006-07-27
US20060165809A1
Human necessities

Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility

 #23 | 2006-07-27
US20060165808A1
Human necessities

Microcapsules for the delayed, controlled release of perindopril

 #24 | 2005-02-17
US20050037077A1
Human necessities

Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles
InventorID:

1358545 ⎘